Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)

Condition:   Asthma Interventions:   Drug: Dupilumab (SAR231893/REGN668);   Drug: Asthma controller therapies (incl. prednisone/prednisolone);   Drug: Asthma reliever therapies Sponsors:   Sanofi;   Regeneron Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials